Indian generic drugmakers launch a price war against Novo Nordisk’s GLP-1 brands, Ozempic and WeGovy.
The executive branch revoked support for organizations it deemed focused on diversity, equity and inclusion. Now a Capital ...
A procedural slipup at the Federal Trade Commission led an appeals court last year to invalidate the click-to-cancel rule.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results